Home / Glimepiride / Czechia
CZ ATC A10BB12 · updated 2 Nov 2026
Glimepiride shortage in Czechia
Is there a Glimepiride shortage in Czechia?
Yes. As of 2 Nov 2026, 12 Glimepiride products are reported short in Czechia, the first since 1 Apr 2026. The company estimate for the return is 13 Nov 2026 (latest 30 Jun 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Austria, Japan. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | GLIMEPIRID MYLAN 4MG 4MG TBL NOB 90 | VIATRIS LIMITED, Dublin | 1 Apr 2026 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID MYLAN 3MG 3MG TBL NOB 90 | VIATRIS LIMITED, Dublin | 1 May 2026 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | OLTAR 1MG 1MG TBL NOB 30 | Menarini | 7 Jul 2026 | 16 Nov 2026 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | GLIMEPIRID SANDOZ 2MG 2MG TBL NOB 120 | Sandoz GmbH, Kundl | 9 Jul 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID SANDOZ 2MG 2MG TBL NOB 30 | Sandoz GmbH, Kundl | 25 Aug 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID SANDOZ 4MG 4MG TBL NOB 120 | Sandoz GmbH, Kundl | 3 Sep 2026 | 13 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID SANDOZ 3MG 3MG TBL NOB 120 | Sandoz GmbH, Kundl | 7 Sep 2026 | 25 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID SANDOZ 1MG 1MG TBL NOB 30 | Sandoz GmbH, Kundl | 17 Sep 2026 | 4 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID MYLAN 3MG 3MG TBL NOB 30 | VIATRIS LIMITED, Dublin | 1 Oct 2026 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID MYLAN 4MG 4MG TBL NOB 30 | VIATRIS LIMITED, Dublin | 1 Oct 2026 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | GLIMEPIRID SANDOZ 4MG 4MG TBL NOB 30 | Sandoz GmbH, Kundl | 26 Oct 2026 | 18 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GLIMEPIRID MYLAN 2MG 2MG TBL NOB 90 anticipated | VIATRIS LIMITED, Dublin | 15 Dec 2026 | 30 Jun 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.